InBrain Pharma to present long-term DIVE-I data at MDS 2025

InBrain Pharma will present long-term follow-up data from its Phase I/II DIVE-I study at the International Conference of Parkinson’s Disease and Movement Disorders (MDS) 2025, to be held October 5–9 in Honolulu, Hawaii, the company said. The oral presentation is scheduled for October 8 at 12:00 pm (HAST), delivered by Prof. David Devos, with an […] The post InBrain Pharma to present long-term DIVE-I data at MDS 2025 appeared first on Longevity.Technology.